New Corporate Website Detailing Company's Digital Prescription Technology and Services Available Now

COLLEYVILLE, TX -- (Marketwire) -- 03/25/09 -- digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS), today released a Letter to Shareholders from Company CEO David Lee. The letter provides an operational update on the Company's proprietary digital prescription software suite and increased sales channels. The letter is included in its entirety below.

Separately, the Company recently launched a new interactive corporate website. The new site, www.digimedical.com, offers doctors, patients, pharmacists and investors a clear view of the company's technology, service offerings and current news and events. Utilizing the latest Microsoft technologies such as .NET, AJAX and Microsoft SQL, the Company has developed a suite of products to digitally manage the prescription process. The company's products comply with all HIPAA and DEA requirements for patient medical record security.

Dear Fellow Shareholders,

We recently launched our new corporate website, detailing our proprietary digital prescription software. Now, I would like to take this opportunity to communicate further updates on company developments over the past months to our shareholders. In this letter, I plan to also discuss our year-to-date progress and our plans for the remainder of 2009, taking into perspective the global economic crisis. Though this economic environment is remarkable, I am confident that digiMedical can not only weather the 'economic storm,' but also prosper from it. There has been a lot of news and renewed focus on small business and its historical role in leading the nation out of past recessions. This trend may be due to a variety of factors, including entrepreneurial spirit, lack of dependence on institutional financing and credit lines, the business agility that comes with a smaller organization or the innovation you find in small business.

Operational Update

Last year, digiMedical shifted its focus to a high margin software revenue model and, accordingly, eliminated high overhead operations. The Company sold its 'brick and mortar' pharmacy chain to reduce the significant overhead costs associated with that part of our business. At the same time, the Company retained ownership of its proprietary digital prescription management suite of software and continued to grow the software user base, both on the prescription origination end, namely clinics and doctors' offices, and on the prescription fulfillment end, namely the pharmacies. Though the Company no longer owns its own pharmacies, the company continues to roll out its software to pharmacies in a purely software driven revenue model.